Therapeutic cell engineering: designing programmable synthetic genetic circuits in mammalian cells

Abstract

Cell therapy approaches that employ engineered mammalian cells for on-demand production of therapeutic agents in the patient’s body are moving beyond proof-of-concept in translational medicine. The therapeutic cells can be customized to sense user-defined signals, process them, and respond in a programmable and predictable way. In this paper, we introduce the available tools and strategies employed to design therapeutic cells. Then, various approaches to control cell behaviors, including open-loop and closed-loop systems, are discussed. We also highlight therapeutic applications of engineered cells for early diagnosis and treatment of various diseases in the clinic and in experimental disease models. Finally, we consider emerging technologies such as digital devices and their potential for incorporation into future cell-based therapies.

Key words： synthetic biology; cell-based therapy; cell engineering; therapeutic gene expression; controllable genetic circuits

References

1 Albinger N , Hartmann J , Ullrich E (2021) Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany. Gene Ther 65: 84- 94

2 Ausländer D , Ausländer S , Charpin-El Hamri G , Sedlmayer F , Müller M , Frey O , Hierlemann A , Stelling J , Fussenegger M (2014) A synthetic multifunctional mammalian pH sensor and CO₂ transgene-control device. Mol Cell 55: 397- 408

3 Bai P , Ye H , Xie M , Saxena P , Zulewski H , Charpin-El Hamri G , Djonov V , Fussenegger M (2016) A synthetic biology-based device prevents liver injury in mice. J Hepatol.

4 Bai P , Liu Y , Xue S , Hamri GCE , Saxena P , Ye H , Xie M , Fussenegger M (2019) A fully human transgene switch to regulate therapeutic protein production by cooling sensation. Nat Med.

5 Beyer HM , Naumann S , Weber W , Radziwill G (2015) Optogenetic control of signaling in mammalian cells. Biotechnol J.

6 Bojar D , Scheller L , Hamri GCE , Xie M , Fussenegger M (2018) Caffeine-inducible gene switches controlling experimental diabetes. Nat Commun 9: 1- 10

7 Bose S , Volpatti LR , Thiono D , Yesilyurt V , McGladrigan C , Tang Y , Facklam A , Wang A , Jhunjhunwala S , Veiseh O et al (2020) A retrievable implant for the long-term encapsulation and survival of therapeutic xenogeneic cells. Nat Biomed Eng 4: 814- 826

8 Brown SA , Kovatchev BP , Raghinaru D , Lum JW , Buckingham BA , Kudva YC , Laffel LM , Levy CJ , Pinsker JE , Wadwa RP et al (2019) Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 381: 1707- 1717

9 Caliendo F , Dukhinova M , Siciliano V (2019) Engineered cell-based therapeutics: synthetic biology meets immunology. Front Bioeng Biotechnol 7: 43

10 Carpenter A , Paulsen I , Williams T (2018) Blueprints for biosensors:design, limitations, and applications. Genes (basel) 9: 375

11 Chen Z , Wang J , Sun W , Archibong E , Kahkoska AR , Zhang X , Lu Y , Ligler FS , Buse JB , Gu Z (2018) Synthetic beta cells for fusionmediated dynamic insulin secretion. Nat Chem Biol 14: 86- 93

12 Chmielewski M , Abken H (2015) TRUCKs: the fourth generation of CARs. Expert Opin Biol Ther.

13 Cho JH , Collins JJ , Wong WW (2018) Universal chimeric antigen receptors for multiplexed and logical control of T cell responses. Cell 173: 1426- 1438.e11

14 Choi BD , Yu X , Castano AP , Bouffard AA , Schmidts A , Larson RC , Bailey SR , Boroughs AC , Frigault MJ , Leick MB et al (2019) CART cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nat Biotechnol 37: 1049- 1058

15 Christiansen MG , Hornslien W , Schuerle PS , Schuerle S (2020) A possible inductive mechanism for magnetogenetics. bioRxiv.

16 Desai T , Shea LD (2017) Advances in islet encapsulation technologies. Nat Rev Drug Discov.

17 Dixon TA , Williams TC , Pretorius IS (2021) Sensing the future of bioinformational engineering. Nat Commun.

18 Dufort CC , Paszek MJ , Weaver VM (2011) Balancing forces:architectural control of mechanotransduction. Nat Rev Mol Cell Biol.

19 Eglen R , Reisine T (2011) Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening. Assay Drug Dev Technol 9: 108- 124

20 Fedorov VD , Themeli M , Sadelain M (2013) PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses. Sci Transl Med.

21 Gaj T , Sirk SJ , Shui S-L , Liu J (2016) Genome-editing technologies:principles and applications. Cold Spring Harb Perspect Biol 8: a023754

22 He L , Zhang Y , Ma G , Tan P , Li Z , Zang S , Wu X , Jing J , Fang S , Zhou L et al (2015) Near-infrared photoactivatable control of Ca²⁺ signaling and optogenetic immunomodulation. Elife 4: e10024

23 Israni DV , Li H-S , Gagnon KA , Sander JD , Roybal KT , Joung JK , Wong WW , Khalil AS (2021) Clinically-driven design of synthetic gene regulatory programs in human cells. bioRxiv.

24 June CH , Sadelain M (2018) Chimeric antigen receptor therapy. N Engl J Med 379: 64- 73

25 Kemmer C , Gitzinger M , Daoud-El Baba M , Djonov V , Stelling J , Fussenegger M (2010) Self-sufficient control of urate homeostasis in mice by a synthetic circuit. Nat Biotechnol 28: 355- 360

26 Khalil AS , Collins JJ (2010) Synthetic biology: applications come of age. Nat Rev Genet 11: 367- 379

27 Kiel C , Yus E , Serrano L (2010) Engineering signal transduction pathways. Cell.

28 Kim J , Campbell AS , de Ávila BEF , Wang J (2019) Wearable biosensors for healthcare monitoring. Nat Biotechnol.

29 Kitada T , DiAndreth B , Teague B , Weiss R (2018) Programming gene and engineered-cell therapies with synthetic biology. Science 359: 1067

30 Klichinsky M , Ruella M , Shestova O , Lu XM , Best A , Zeeman M , Schmierer M , Gabrusiewicz K , Anderson NR , Petty NE et al (2020) Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat Biotechnol 38: 947- 953

31 Kloss CC , Condomines M , Cartellieri M , Bachmann M , Sadelain M (2013) Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells. Nat Biotechnol 31: 71- 75

32 Kojima R , Aubel D , Fussenegger M (2016) Toward a world of theranostic medication: programming biological sentinel systems for therapeutic intervention. Adv Drug Deliv Rev.

33 Kojima R , Scheller L , Fussenegger M (2018) Nonimmune cells equipped with T-cell-receptor-like signaling for cancer cell ablation. Nat Chem Biol 14: 42- 49

34 Kojima R , Aubel D , Fussenegger M (2020) Building sophisticated sensors of extracellular cues that enable mammalian cells to work as “doctors” in the body. Cell Mol Life Sci.

35 Kolar K , Weber W (2017) Synthetic biological approaches to optogenetically control cell signaling. Curr Opin Biotechnol.

36 Krawczyk K , Xue S , Buchmann P , Charpin-El-Hamri G , Saxena P , Hussherr MD , Shao J , Ye H , Xie M , Fussenegger M (2020) Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice. Science 368: 993- 1001

37 Li J , Liang JY , Laken SJ , Langer R , Traverso G (2020) Clinical opportunities for continuous biosensing and closed-loop therapies. Trends Chem.

38 Lim WA , June CH (2017) Review the principles of engineering immune cells to treat cancer. Cell 168: 724- 740

39 Liu Y , Bai P , Woischnig AK , Charpin-El Hamri G , Ye H , Folcher M , Xie M , Khanna N , Fussenegger M (2018) Immunomimetic designer cells protect mice from MRSA infection. Cell 174: 259- 270

40 Lohmueller J , Butchy A , Tivon Y , Kvorjak M , Miskov-Zivanov N , Deiters A , Finn O (2020) Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting. bioRxiv.

41 Maggio I , Gonçalves MAFV (2015) Genome editing at the crossroads of delivery, specificity, and fidelity. Trends Biotechnol 33: 280- 291

42 Mansouri M , Berger P (2018) Multigene delivery in mammalian cells:recent advances and applications. Biotechnol Adv.

43 Mansouri M , Bellon-Echeverria I , Rizk A , Ehsaei Z , Cianciolo Cosentino C , Silva CS , Xie Y , Boyce FM , Davis MW et al (2016) Highly efficient baculovirus-mediated multigene delivery in primary cells. Nat Commun 7: 11529

44 Mansouri M , Strittmatter T , Fussenegger M (2019) Light-controlled mammalian cells and their therapeutic applications in synthetic biology. Adv Sci (weinh).

45 Mansouri M , Hussherr M-D , Strittmatter T , Buchmann P , Xue S , Camenisch G , Fussenegger M (2021a) Smart-watch-programmed green-light-operated percutaneous control of therapeutic transgenes. Nat Commun 12: 3388

46 Mansouri M , Xue S , Hussherr M-D , Strittmatter T , Camenisch G , Fussenegger M (2021b) Smartphone-flashlight-mediated remote control of rapid insulin secretion restores glucose homeostasis in experimental type-1 diabetes. Small.

47 Marx V (2015) Cell biology: delivering tough cargo into cells. Nat Methods 13: 37- 40

48 Matsunaga S , Jeremiah SS , Miyakawa K , Kurotaki D , Shizukuishi S , Watashi K , Nishitsuji H , Kimura H , Tamura T , Yamamoto N et al (2020) Engineering cellular biosensors with customizable antiviral responses targeting hepatitis B virus. Science 23: 100867

49 Maurisse R , De Semir D , Emamekhoo H , Bedayat B , Abdolmohammadi A , Parsi H , Gruenert DC (2010) Comparative transfection of DNA into primary and transformed mammalian cells from different lineages. BMC Biotechnol 10: 9

50 McClune CJ , Alvarez-Buylla A , Voigt CA , Laub MT (2019) Engineering orthogonal signalling pathways reveals the sparse occupancy of sequence space. Nature 574: 702- 706

51 Miller IC , Gamboa Castro M , Maenza J , Weis JP , Kwong GA (2018) Remote control of mammalian cells with heat-triggered gene switches and photothermal pulse trains. ACS Synth Biol 7: 1167- 1173

52 Morsut L , Roybal KTKT , Xiong X , Gordley RM , Coyle SM , Thomson M , Lim WAWA (2016) Engineering customized cell sensing and response behaviors using synthetic notch receptors. Cell 164: 780- 791

53 Mukherjee A , Repina NA , Schaffer DV , Kane RS (2017) Optogenetic tools for cell biological applications. J Thorac Dis.

54 Müller K , Naumann S , Weber W , Zurbriggen MD (2015) Optogenetics for gene expression in mammalian cells. Biol Chem.

55 Mure LSS , Hatori M , Zhu Q , Demas J , Kim IMM , Nayak SKK , Panda S (2016) Melanopsin-encoded response properties of intrinsically photosensitive retinal ganglion cells. Neuron 90: 1016- 1027

56 Neelapu SS , Tummala S , Kebriaei P , Wierda W , Gutierrez C , Locke FL , Komanduri KV , Lin Y , Jain N , Daver N et al (2018) Chimeric antigen receptor T-cell therapy-assessment and management of toxicities. Nat Rev Clin Oncol.

57 Pan Y , Yoon S , Sun J , Huang Z , Lee C , Allen M , Wu Y , Chang YJ , Sadelain M , Kirk Shung K et al (2018) Mechanogenetics for the remote and noninvasive control of cancer immunotherapy. Proc Natl Acad Sci USA 115: 992- 997

58 Papapetrou EP , Schambach A (2016) Gene insertion into genomic safe harbors for human gene therapy. Mol Ther.

59 Park JS , Rhau B , Hermann A , McNally KA , Zhou C , Gong D , Weiner OD , Conklin BR , Onuffer J , Lim WA (2014) Synthetic control of mammalian-cellmotility by engineering chemotaxis to anorthogonal bioinert chemical signal. Proc Natl Acad Sci USA 111: 5896- 5901

60 Polonsky KS , Given BD , Van Cauter E (1988) Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 81: 442- 448

61 Rafiq S , Hackett CS , Brentjens RJ (2020) Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat Rev Clin Oncol 1: 1

62 Rivera VM , Wang X , Wardwell S , Courage NL , Volchuk A , Keenan T , Holt DA , Gilman M , Orci L , Cerasoli F et al (2000) Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum. Science 287: 826- 830

63 Rössger K , Charpin-El-Hamri G , Fussenegger M (2013a) A closedloop synthetic gene circuit for the treatment of diet-induced obesity in mice. Nat Commun 4: 1- 9

64 Rössger K , Charpin-El Hamri G , Fussenegger M (2013b) Reward-based hypertension control by a synthetic brain-dopamine interface. Proc Natl Acad Sci USA 110: 18150- 18155

65 Roybal KT , Lim WA (2017) Synthetic immunology: hacking immune cells to expand their therapeutic capabilities. Annu Rev Immunol.

66 Roybal KT , Rupp LJ , Morsut L , Walker WJ , McNally KA , Park JS , Lim WA , Box C , Eccles SA , Maher J et al (2016a) Precision tumor recognition by T cells with combinatorial antigen-sensing circuits. Cell 164: 770- 779

67 Roybal KT , Williams JZ , Morsut L , Rupp LJ , Kolinko I , Choe JH , Walker WJ , McNally KA , Lim WA , Rupp LJ et al (2016b) Engineering T cells with customized therapeutic response programs using synthetic notch receptors. Cell.

68 Saxena P , Hamri GCE , Folcher M , Zulewski H , Fussenegger M (2016a) Synthetic gene network restoring endogenous pituitary-thyroid feedback control in experimental Graves’ disease. Proc Natl Acad Sci USA 113: 1244- 1249

69 Saxena P , Heng BC , Bai P , Folcher M , Zulewski H , Fussenegger M (2016b) A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells. Nat Commun 7: 1- 14

70 Saxena P , Bojar D , Zulewski H , Fussenegger M (2017) Generation of glucose-sensitive insulin-secreting beta-like cells from human embryonic stem cells by incorporating a synthetic lineage-control network. J Biotechnol 259: 39- 45

71 Scheller L , Fussenegger M (2019) From synthetic biology to human therapy: engineered mammalian cells. Curr Opin Biotechnol 58: 108- 119

72 Scheller L , Strittmatter T , Fuchs D , Bojar D , Fussenegger M (2018) Generalized extracellular molecule sensor platform for programming cellular behavior. Nat Chem Biol 14: 723- 729

73 Schmidt P , Raftery MJ , Pecher G (2021) Engineering NK cells for CAR therapy-recent advances in gene transfer methodology. Front Immunol.

74 Schukur L , Fussenegger M (2016) Engineering of synthetic gene circuits for (re-)balancing physiological processes in chronic diseases. Wiley Interdiscip Rev Syst Biol Med 8: 402- 422

75 Schukur L , Geering B , Charpin-El Hamri G , Fussenegger M (2015) Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis. Sci Transl Med 7: 318318ra201

76 Sedlmayer F , Hell D , Müller M , Ausländer D , Fussenegger M (2018) Designer cells programming quorum-sensing interference with microbes. Nat Commun 9: 1- 13

77 Shao J , Xue S , Yu G , Yu Y , Yang X , Bai Y , Zhu S , Yang L , Yin J , Wang Y et al (2017) Smartphone-controlled optogenetically engineered cells enable semiautomatic glucose homeostasis in diabetic mice. Sci Transl Med 9: eaal2298

78 Sim I (2019) Mobile devices and health. N Engl J Med.

79 Slattery D , Choudhary P (2017) Clinical use of continuous glucose monitoring in adults with type 1 diabetes. Diabetes Technol Ther.

80 Stanley SA , Gagner JE , Damanpour S , Yoshida M , Dordick JS , Friedman JM (2012) Radio-wave heating of iron oxide nanopar-ticles can regulate plasma glucose in mice. Science 336: 604- 608

81 Steinhubl SR , Muse ED , Topol EJ (2015) The emerging field of mobile health. Sci. Transl. Med.

82 Su Y , Huang X , Huang Z , Huang T , Li T , Fan H , Zhang K , Yi C (2020) Early but not delayed optogenetic RAF activation promotes astrocytogenesis in mouse neural progenitors. J Mol Biol 432: 4358- 4368

83 Sun J , Lei L , Tsai CM , Wang Yi , Shi Y , Ouyang M , Lu S , Seong J , Kim TJ , Wang P et al (2017) Engineered proteins with sensing and activating modules for automated reprogramming of cellular functions. Nat Commun 8: 1- 10

84 Tastanova A , Folcher M , Müller M , Camenisch G , Ponti A , Horn T , Tikhomirova MS , Fussenegger M (2018) Synthetic biology-based cellular biomedical tattoo for detection of hypercalcemia associated with cancer. Sci Transl Med 10: 8562

85 Toda S , Blauch LR , Tang SKY , Morsut L , Lim WA (2018) Programming self-organizing multicellular structures with synthetic cellcell signaling. Science 361: 156- 162

86 Wang X , Chen X , Yang Y (2012) Spatiotemporal control of gene expression by a light-switchable transgene system. Nat Methods 9: 266- 269

87 Wang H , Xie M , Charpin-El Hamri G , Ye H , Fussenegger M (2018a) Treatment of chronic pain by designer cells controlled by spearmint aromatherapy. Nat Biomed Eng 2: 114- 123

88 Wang Y , Wang M , Dong K , Ye H (2018b) Engineering mammalian designer cells for the treatment of metabolic diseases. Biotechnol J 13: 1700160

89 Weber W , Fussenegger M (2004) Inducible gene expression in mammalian cells and mice. Methods Mol Biol 267: 451- 466

90 Xie M , Fussenegger M (2015) Mammalian designer cells: engineering principles and biomedical applications. Biotechnol J.

91 Xie M , Fussenegger M (2018) Designing cell function: assembly of synthetic gene circuits for cell biology applications. Nat Rev Mol Cell Biol.

92 Xie M , Haellman V , Fussenegger M (2016a) Synthetic biology -application-oriented cell engineering. Curr Opin Biotechnol.

93 Xie M , Ye H , Wang H , Charpin-El Hamri G , Lormeau C , Saxena P , Stelling J , Fussenegger M (2016b) β-cell-mimetic designer cells provide closed-loop glycemic control. Science 354: 1296- 1301

94 Xue S , Yin J , Shao J , Yu Y , Yang L , Wang Y , Xie M , Fussenegger M , Ye H (2017) A synthetic-biology-inspired therapeutic strategy for targeting and treating hepatogenous diabetes. Mol Ther 25: 443- 455

95 Yamada M , Nagasaki SC , Ozawa T , Imayoshi I (2020) Lightmediated control of gene expression in mammalian cells. Neurosci Res.

96 Ye H , Baba MDE , Peng RW , Fussenegger M (2011) A synthetic optogenetic transcription device enhances blood-glucose homeostasis in mice. Science 332: 1565- 1568

97 Yip A , Webster RM (2018) The market for chimeric antigen receptor T cell therapies. Nat Rev Drug Discov 17: 161- 162

98 Zhang F , Tzanakakis ES (2019) Amelioration of diabetes in a murine model upon transplantation of pancreatic β-cells with optogenetic control of cyclic adenosine monophosphate. ACS Synth Biol 8: 2248- 2255

99 Zhu L , Wu Y , Yoon CW , Wang Y (2020) Mechanogenetics for cellular engineering and cancer immunotherapy. Curr Opin Biotechnol.